Welcome to CDC Stacks | How a parasite causes lymphatic filariasis, known as elephantiasis - 34171 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
How a parasite causes lymphatic filariasis, known as elephantiasis
  • Published Date:
    August 5, 2015
  • Language:
    English
Filetype[PDF - 35.30 KB]


Details:
  • Corporate Authors:
    Center for Global Health (U.S.) ; Rotary International ;
  • Keywords:
  • Description:
    Wuchereria bancrofti is one of the parasites that causes the painful, infectious disease.

    Human Stages:

    1. Mosquito takes a blood meal (L3 larvae enter skin)

    2. Adults in lymphatics

    3. Adults produce sheathed microfilariae that migrate into lymph and blood channels

    Mosquito Stages:

    4. Mosquito takes a blood meal (ingests microfilariae)

    5. Microfilariae shed sheaths, penetrate mosquito's midgut, and migrate to thoracic muscles

    6. L1 larvae

    7. L3 larvae

    8. Migrate to head and mosquito's proboscis

    parasite_lymphatic_filariasis

  • Document Type:
    Poster
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Lymphatic Filariasis in Nigeria; Micro-stratification Overlap Mapping (MOM) as a Prerequisite for Cost-Effective Resource Utilization in Control and Surveillance
    Personal Author:
    Okorie, Patricia N.; Ademowo, George O.; Saka, Yisa; Davies, Emmanuel; Okoronkwo, Chukwu; Bockarie, Moses J.; Molyneux, David H.; Kelly-Hope, Louise A.;
    Published:
    2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(9).
    Description:
    Background : Nigeria has a significant burden of lymphatic filariasis (LF) caused by the parasite Wuchereria bancrofti. A major concern to the expansion of the LF elimination programme is the risk of serious adverse events (SAEs) associated with the ...
    File Type:
    Filetype[PDF - 3.70 MB]
  2. Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion”
    Personal Author:
    Addiss, David G.
    Published:
    2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(8).
    File Type:
    Filetype[PDF - 118.09 KB]
  3. Endpoints for Lymphatic Filariasis Programs
    Personal Author:
    Grady, Caroline A.; Beau de Rochars, Madsen; Direny, Abdel N.; Orelus, Jean Nicolas; Wendt, Joyanna; Radday, Jeanne; Mathieu, Els; Roberts, Jacquelin M.; Streit, Thomas G.; Addiss, David G.; Lammie, Patrick J.;
    Published:
    Apr 2007
    Source:
    Emerg Infect Dis. 13(4):608-610.
    Description:
    In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates w...
    File Type:
    Filetype[PDF - 93.33 KB]
  4. Policy brief : Lymphatic filariasis (LF)
    Corporate Author:
    Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.
    Published:
    July 2014
    Description:
    To date, close to 700 million individuals in some of the poorest areas globally have received treatment to prevent one of the world’s most incapacitating diseases, lymphatic filariasis. : Lymphatic filariasis (LF) is a disabling parasitic disease c...
    File Type:
    Filetype[PDF - 467.46 KB]
  5. Disability Measurement for Lymphatic Filariasis: A Review of Generic Tools Used within Morbidity Management Programs
    Personal Author:
    Zeldenryk, Lynne; Gordon, Susan; Gray, Marion; Speare, Richard; Melrose, Wayne;
    Published:
    Sep 27 2012
    Source:
    PLoS Negl Trop Dis. 2012; 6(9).
    Description:
    Lymphatic filariasis (LF)-related disability affects 40 million people globally, making LF the leading cause of physical disability in the world. Despite this, there is limited research into how the impacts of LF-related disability are best measured....
    File Type:
    Filetype[PDF - 155.48 KB]